IFP Advisors’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$140 Hold
110
– – ﹤0.01% 4928
2026
Q2
$205 Hold
110
– – ﹤0.01% 4853
2026
Q1
$245 Sell
110
-100
-48% -$274 ﹤0.01% 4579
2025
Q4
$727 Hold
210
– – ﹤0.01% 4172
2025
Q3
$435 Buy
210
+100
+91% +$250 ﹤0.01% 4214
2025
Q2
$239 Buy
+110
New +$217 ﹤0.01% 4599
2023
Q1
– Sell
-4,600
Closed -$44K – 3396
2022
Q4
$44K Hold
4,600
– – ﹤0.01% 2323
2022
Q3
$44K Buy
4,600
+4,000
+667% +$52.6K ﹤0.01% 2454
2022
Q2
$6K Hold
600
– – ﹤0.01% 3655
2022
Q1
$6K Buy
+600
New +$8.67K ﹤0.01% 3653

Other funds holding ANVS

IFP Advisors's ANVS Position: Q3 2026 in Review

IFP Advisors held its Annovis Bio (ANVS) position steady in Q3 2026 at 110 shares worth $140. The position accounts for ﹤0.01% of the portfolio, ranked #4928.

IFP Advisors first reported a position in ANVS in Q1 2022 and has held it in 10 quarters since. The position peaked at $44K in Q4 2022. 49 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • IFP Advisors held 110 shares of Annovis Bio worth $140 as of Q3 2026.
  • IFP Advisors left its Annovis Bio share count unchanged in Q3 2026.
  • Annovis Bio made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4928 holding.
  • IFP Advisors first reported a position in Annovis Bio in Q1 2022 and has held it in 10 quarters since.
  • IFP Advisors's Annovis Bio position peaked at $44K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.